CHANGE IN RATINGS

ArvinMeritor was upgraded from Underperform to Outperform at Bear Stearns. Stock has 26% upside over the next 18 months, as the company re-makes itself. Recovery could be similar to Navistar.

Cohen & Steers ( CNS) was upgraded at UBS to Buy from Neutral due to strong underlying growth drivers. Raised target price to $55 from $48.

Carter's ( CRI) downgraded at Credit Suisse to Neutral from Outperform based on valuation. Cites stock is up 32% since Q4. Maintained $28 stock price.

Dover ( DOV) upgraded at Deutsche from Hold to Buy. $56 price target. Stock has underperformed its peers by 9% on the year, but business trends look solid outside of the Technologies division.

Graco ( GGG) was downgraded to Market Perform at Friedman, Billings Ramsey. Estimates also cut, as the company remains leveraged to a slowdown in US housing. $43 price target.

Goldman is upgrading Corning ( GLW - Get Report) to Buy from Neutral based on continuing top-line growth and expectations for margin expansion. Despite 25% gain this year, see successful pricing strategy and strong demand for optical fiber. Target price raised to $31 from $26.

Panera Bread ( PNRA) was downgraded from Outperform to Market Perform at Friedman, Billings Ramsey. Company's guidance looks too optimistic for the second half of the year, as cost pressures continue to linger. $65 price target.

Praxair ( PX) was upgraded from Neutral to Overweight at JP Morgan. Estimates also bumped up through 2008, as the company's investments should deliver above-average growth.

Reynolds American ( RAI) was upgraded at JP Morgan to Neutral. $70 price target. Estimates also raised, as the company saw strong results both in cigarettes and smokeless tobacco.

UAL downgraded to Neutral from Buy at Goldman. Expect poor cost performance resulting in below-average margin performance in 2007. Other weaknesses include less financial transparency and low investor confidence in management. Also see low-cost carrier competition becoming a bigger issue. Price target cut to $35 from $44.

Varian Medical ( VAR - Get Report) downgraded at Jefferies to Hold from Buy, based on disappointing oncology order growth and competitive pressures. Q2 results showed oncology system orders grew only 2% overall, with a 10% year-over-year decrease in U.S. Price target cut to $45 from $62.

Varian Medical was downgraded from Outperform to Neutral at Robert Baird. $63 price target. Valuation call, as growth should moderate in the second half of the year.

Verasun was initiated with an Outperform rating at Piper Jaffray. $23 price target. Stock is trading at a 20% discount to the other pure-play ethanol companies and oil refiners. Prices should only move higher, when the summer fuel season begins in a couple of weeks.

STOCK COMMENTS / EPS CHANGES

UBS is raising its target price on Apple ( AAPL - Get Report) to $133 from $124 after blow-out quarter and hints at exiting subscription offerings. Maintained Buy rating.

Apple 2007 estimates raised at Credit Suisse to $3.56 from $3.21 following strong Q2 results. Maintained Outperform rating and $120 target price.

Akamai ( AKAM - Get Report) 2007 estimates cut at Credit Suisse to $0.94 from $0.98 after Q1 results fell short of its forecast. Maintained Outperform rating.

LSI Logic ( LSI) 2007 estimates slashed at Goldman to $0.17 from $0.32, based on disappointing sales trends in both organic and acquired businesses (Agere). Top line results down 11% quarter-over-quarter. management committed to reduce operating expense by $50 in the second half of 2007. Price target lowered to $10.50 from $11.50 and maintained Neutral rating.

McDonald's ( MCD - Get Report) target price raised at UBS to $57 from $53. Cites stock drivers are in place for 2007 and 2008. Maintained Buy rating.

Qualcomm ( QCOM) target price raised at Credit Suisse to $58 from $52 after company reported solid Q2 results and strong guidance. Maintained Outperform rating.